دورية أكاديمية

Uterine infusion strategies for infertile patients with recurrent implantation failure: a systematic review and network meta-analysis

التفاصيل البيبلوغرافية
العنوان: Uterine infusion strategies for infertile patients with recurrent implantation failure: a systematic review and network meta-analysis
المؤلفون: Qin Xie, Xiaozhen Quan, Yanli Lan, Xuezhou Yang
المصدر: Reproductive Biology and Endocrinology, Vol 22, Iss 1, Pp 1-12 (2024)
بيانات النشر: BMC, 2024.
سنة النشر: 2024
المجموعة: LCC:Gynecology and obstetrics
LCC:Reproduction
مصطلحات موضوعية: Repeated implantation failure (RIF), Intra-uterine infusion, Platelet-rich plasma (PRP), Granulocyte Colony-Stimulating Factor (G-CSF), Peripheral Blood Mononuclear Cell (PBMC), Gynecology and obstetrics, RG1-991, Reproduction, QH471-489
الوصف: Abstract Background Intra-uterine infusion treatments were reported to be beneficial to embryo implantation and pregnancy outcomes, and considered as potential therapies for infertile patients with recurrent implantation failure (RIF). Nevertheless, their efficiencies were controversial and there lack of consensus on which intrauterine treatment is the most effective. Methods All prospective trials (in Chinese or English) were searched in Databases PubMed, Cochrane, Web of Science, and CNKI from July 2013 to July 2023. We included studies that investigated various uterine infusions, including chorionic gonadotropin, granulocyte colony-stimulating factor, monocytes, platelet-rich plasma, etc. during IVF treatment and reported subsequent pregnancy outcomes. Results We finally included 56 researches, including 40 randomized controlled trials, 14 non-randomized controlled trials, and 3 prospective cohort studies. This study included a total of 11 uterine perfusion methods: Placebo, Human Chorionic Gonadotropin (HCG), Granulocyte Colony-Stimulating Factor (G-CSF), platelet-rich plasma (PRP), Peripheral Blood Mononuclear Cell (PBMC), Growth hormone (GH), dexamethasone (DEX), Embryo culture supernatant (ESC), PRP combined with G-CSF (PRP + G-CSF), RPR combined with subcutaneous injection of G-CSF (RPR + G-CSFsc), G-CSF combined with subcutaneous injection of AXaIU (G-CSF + AXaIUsc). Intrauterine infusion of HCG, PBMC, G-CSF, and PRP significantly improves pregnancy outcomes in patients with repeated implantation failure compared with blank controls or placebo, and PRP improved the clinical pregnancy and live birth most. GH and ESC infusion might improve the pregnancy outcomes, but uterine infusion of DEX was shown with high miscarriage. The combination therapy did not show a significant advantage over the mono-therapy. Conclusions Intrauterine infusion of HCG, PBMC, G-CSF, and PRP are promising strategies for improving pregnancy outcomes for infertile patients with recurrent implantation failure. Among these treatments, PRP may be the best. More researches are required to explore the effect of drug combinations and less commonly used drugs as well. Trial registration Our study was registered in PROSPERO and the ID was CRD42023467188.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1477-7827
العلاقة: https://doaj.org/toc/1477-7827Test
DOI: 10.1186/s12958-024-01221-x
الوصول الحر: https://doaj.org/article/35f5915fccc648e8a48923acde7baa3bTest
رقم الانضمام: edsdoj.35f5915fccc648e8a48923acde7baa3b
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14777827
DOI:10.1186/s12958-024-01221-x